Sugarloaf Wealth Management, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sugarloaf Wealth Management, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$5,0000.0%1500.0%0.00%0.0%
Q1 2022$5,000
+25.0%
1500.0%0.00%0.0%
Q4 2021$4,0000.0%1500.0%0.00%0.0%
Q3 2021$4,000
-71.4%
150
-62.5%
0.00%
-75.0%
Q2 2021$14,000
-12.5%
4000.0%0.00%
-20.0%
Q1 2021$16,000
-5.9%
4000.0%0.01%
-16.7%
Q4 2020$17,000
-10.5%
400
+14.3%
0.01%
-14.3%
Q3 2020$19,000
-13.6%
3500.0%0.01%
-12.5%
Q2 2020$22,000
+22.2%
3500.0%0.01%0.0%
Q1 2020$18,000
-35.7%
3500.0%0.01%
-33.3%
Q4 2019$28,0003500.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders